Maturation of SARS-CoV-2 Spike-specific Memory B Cells Drives Resilience to Viral Escape

Memory B cells (MBCs) generate rapid antibody responses upon secondary encounter with a pathogen. Here, we investigated the kinetics, avidity and cross-reactivity of serum antibodies and MBCs in 155 SARS-CoV-2 infected and vaccinated individuals over a 16-month timeframe. SARS-CoV-2-specific MBCs and serum antibodies reached steady-state titers with comparable kinetics in infected and vaccinated individuals. Whereas MBCs of infected individuals targeted both pre- and postfusion Spike (S), most vaccine-elicited MBCs were specific for prefusion S, consistent with the use of prefusion-stabilized S in mRNA vaccines. Furthermore, a large fraction of MBCs recognizing postfusion S cross-reacted with human betacoronaviruses. The avidity of MBC-derived and serum antibodies increased over time resulting in enhanced resilience to viral escape by SARS-CoV-2 variants, including Omicron BA.1 and BA.2 sub-lineages, albeit only partially for BA.4 and BA.5 sublineages. Overall, the maturation of high-affinity and broadly-reactive MBCs provides the basis for effective recall responses to future SARS-CoV-2 variants.

Citing Articles

Immune escape of SARS-CoV-2 variants to therapeutic monoclonal antibodies: a system review and meta-analysis.

Shi H, Sun J, Zeng Y, Wang X, Liu S, Zhang L Virol J. 2023; 20(1):266.

PMID: 37968649 PMC: 10652597. DOI: 10.1186/s12985-023-01977-5.

References

Pallesen J, Wang N, Corbett K, Wrapp D, Kirchdoerfer R, Turner H . Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017; 114(35):E7348-E7357. PMC: 5584442. DOI: 10.1073/pnas.1707304114. View

Garcia-Beltran W, Lam E, St Denis K, Nitido A, Garcia Z, Hauser B . Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell. 2021; 184(9):2372-2383.e9. PMC: 7953441. DOI: 10.1016/j.cell.2021.03.013. View

Cele S, Gazy I, Jackson L, Hwa S, Tegally H, Lustig G . Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma. Nature. 2021; 593(7857):142-146. PMC: 9867906. DOI: 10.1038/s41586-021-03471-w. View

Cameroni E, Bowen J, Rosen L, Saliba C, Zepeda S, Culap K . Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift. Nature. 2022; 602(7898):664-670. PMC: 9531318. DOI: 10.1038/s41586-021-04386-2. View

Bowen J, Addetia A, Dang H, Stewart C, Brown J, Sharkey W . Omicron spike function and neutralizing activity elicited by a comprehensive panel of vaccines. Science. 2022; 377(6608):890-894. PMC: 9348749. DOI: 10.1126/science.abq0203. View

Meng B, Abdullahi A, Ferreira I, Goonawardane N, Saito A, Kimura I . Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022; 603(7902):706-714. PMC: 8942856. DOI: 10.1038/s41586-022-04474-x. View

Rodda L, Netland J, Shehata L, Pruner K, Morawski P, Thouvenel C . Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19. Cell. 2020; 184(1):169-183.e17. PMC: 7682481. DOI: 10.1016/j.cell.2020.11.029. View

Forster P, Forster L, Renfrew C, Forster M . Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020; 117(17):9241-9243. PMC: 7196762. DOI: 10.1073/pnas.2004999117. View

Walls A, Sprouse K, Bowen J, Joshi A, Franko N, Navarro M . SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses. Cell. 2022; 185(5):872-880.e3. PMC: 8769922. DOI: 10.1016/j.cell.2022.01.011. View

10.

Pinto D, Sauer M, Czudnochowski N, Low J, Tortorici M, Housley M . Broad betacoronavirus neutralization by a stem helix-specific human antibody. Science. 2021; 373(6559):1109-1116. PMC: 9268357. DOI: 10.1126/science.abj3321. View

11.

Supasa P, Zhou D, Dejnirattisai W, Liu C, Mentzer A, Ginn H . Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell. 2021; 184(8):2201-2211.e7. PMC: 7891044. DOI: 10.1016/j.cell.2021.02.033. View

12.

Bowen J, Park Y, Stewart C, Brown J, Sharkey W, Walls A . SARS-CoV-2 spike conformation determines plasma neutralizing activity elicited by a wide panel of human vaccines. Sci Immunol. 2022; 7(78):eadf1421. PMC: 9765460. DOI: 10.1126/sciimmunol.adf1421. View

13.

Sokal A, Chappert P, Barba-Spaeth G, Roeser A, Fourati S, Azzaoui I . Maturation and persistence of the anti-SARS-CoV-2 memory B cell response. Cell. 2021; 184(5):1201-1213.e14. PMC: 7994111. DOI: 10.1016/j.cell.2021.01.050. View

14.

Vogel A, Kanevsky I, Che Y, Swanson K, Muik A, Vormehr M . BNT162b vaccines protect rhesus macaques from SARS-CoV-2. Nature. 2021; 592(7853):283-289. DOI: 10.1038/s41586-021-03275-y. View

15.

Lempp F, Soriaga L, Montiel-Ruiz M, Benigni F, Noack J, Park Y . Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021; 598(7880):342-347. DOI: 10.1038/s41586-021-03925-1. View

16.

Goel R, Painter M, Apostolidis S, Mathew D, Meng W, Rosenfeld A . mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern. Science. 2021; 374(6572):abm0829. PMC: 9284784. DOI: 10.1126/science.abm0829. View

17.

Wrapp D, Wang N, Corbett K, Goldsmith J, Hsieh C, Abiona O . Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020; 367(6483):1260-1263. PMC: 7164637. DOI: 10.1126/science.abb2507. View

18.

Viana R, Moyo S, Amoako D, Tegally H, Scheepers C, Althaus C . Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature. 2022; 603(7902):679-686. PMC: 8942855. DOI: 10.1038/s41586-022-04411-y. View

19.

Walls A, Park Y, Tortorici M, Wall A, McGuire A, Veesler D . Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181(2):281-292.e6. PMC: 7102599. DOI: 10.1016/j.cell.2020.02.058. View

20.

Park Y, Pinto D, Walls A, Liu Z, De Marco A, Benigni F . Imprinted antibody responses against SARS-CoV-2 Omicron sublineages. Science. 2022; 378(6620):619-627. DOI: 10.1126/science.adc9127. View